Kasar S, Brown J R
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Mol Cell Oncol. 2016 Mar 10;3(4):e1157667. doi: 10.1080/23723556.2016.1157667. eCollection 2016 Jul.
Sequencing studies have been instrumental in understanding the genetic basis of chronic lymphocytic leukemia (CLL). Our recent whole-genome sequencing study focusing on lower cytogenetic risk CLL demonstrated that CLL mutations can be attributed to 3 key mutational processes-2 types of activation induced-cytidine deaminase (AID) signatures and an aging signature-that operate at different times throughout CLL evolution.
测序研究在理解慢性淋巴细胞白血病(CLL)的遗传基础方面发挥了重要作用。我们最近针对低细胞遗传学风险CLL的全基因组测序研究表明,CLL突变可归因于3个关键的突变过程——2种激活诱导胞嘧啶脱氨酶(AID)特征和一种衰老特征,这些过程在CLL整个病程的不同时间发挥作用。